UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

State-of-the-art acute and chronic GVHD treatment

International journal of hematology, 2015-05, Vol.101 (5), p.452-466

2015

Volltextzugriff (PDF)

Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance

Frontiers in immunology, 2019-02, Vol.10, p.93-93

2019

Volltextzugriff (PDF)

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

The New England journal of medicine, 2012-10, Vol.367 (16), p.1487-1496

2012

Volltextzugriff (PDF)

Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia

International journal of molecular sciences, 2024-01, Vol.25 (2), p.957

2024

Volltextzugriff (PDF)

VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML

Oncoimmunology, 2018-09, Vol.7 (9), p.e1469594-e1469594

2018

Volltextzugriff (PDF)

In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

PloS one, 2016-12, Vol.11 (12), p.e0166891

2016

Volltextzugriff (PDF)

A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia

American journal of hematology, 2021-02, Vol.96 (2), p.E46-E50

2021

Volltextzugriff (PDF)

Phase II clinical trial of one dose of post‐transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched‐unrelated donor transplantation

American journal of hematology, 2021-10, Vol.96 (10), p.E396-E398

2021

Volltextzugriff (PDF)

Multi‐dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML

British journal of haematology, 2020-03, Vol.188 (5), p.674-684

2020

Volltextzugriff (PDF)

The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma

Transplant infectious disease, 2024-04, Vol.26 (2), p.e14241-e14241

2024

Volltextzugriff (PDF)

Clofarabine followed by haploidentical stem cell transplant using fludarabine, busulfan, and total-body irradiation with post-transplant cyclophosphamide in non-remission AML

International journal of hematology, 2018-09, Vol.108 (3), p.348-350

2018

Volltextzugriff (PDF)

Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes

Haematologica (Roma), 2013-02, Vol.98 (2), p.179-184

2013

Volltextzugriff (PDF)

Elafin is a biomarker of graft-versus-host disease of the skin

Science translational medicine, 2010-01, Vol.2 (13), p.13ra2

2010

Volltextzugriff (PDF)

The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation

The Journal of immunology (1950), 2016-02, Vol.196 (3), p.1070-1080

2016

Volltextzugriff (PDF)

IMPROVE-BMT: a protocol for a pilot randomised controlled trial of prehabilitation exercise for adult haematopoietic stem cell transplant recipients

BMJ open, 2023-01, Vol.13 (1), p.e066841-e066841

2023

Volltextzugriff (PDF)

Alloantigen-activated (AAA) CD4 + T cells reinvigorate host endogenous T cell immunity to eliminate pre-established tumors in mice

Journal of experimental & clinical cancer research, 2021-10, Vol.40 (1), p.314-314, Article 314

2021

Volltextzugriff (PDF)

Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients

Blood cancer journal (New York), 2018-03, Vol.8 (3), p.34-5, Article 34

2018

Volltextzugriff (PDF)

CD26lowPD-1+ CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia

Frontiers in immunology, 2023-06, Vol.14, p.1169144-1169144

2023

Volltextzugriff (PDF)

IMPROVE-BMT: A Pilot Randomized Controlled Trial of Prehabilitation Exercise for Adult Hematopoietic Stem Cell Transplant Recipients

Journal of clinical medicine, 2024-04, Vol.13 (7), p.2052

2024

Volltextzugriff (PDF)

Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion

Annals of hematology, 2021-10, Vol.100 (10), p.2585-2592

2021

Volltextzugriff (PDF)

Seatbelts in CAR therapy: How Safe Are CARS?

Pharmaceuticals (Basel, Switzerland), 2015-05, Vol.8 (2), p.230-249

2015

Volltextzugriff (PDF)

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

Blood, 2008-02, Vol.111 (4), p.2470-2475

2008

Volltextzugriff (PDF)

Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant

Bone marrow transplantation (Basingstoke), 2018-10, Vol.53 (10), p.1345-1348

2018

Volltextzugriff (PDF)

1 – 25 von 251

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(222)

Publikationsform

Sprache

Englisch
(242)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(106)
Life Sciences & Biomedicine
(105)
Humans
(94)
Hematology
(66)
Male
(49)
Female
(45)
Adult
(43)
Middle Aged
(40)
Transplantation
(39)
Immunology
(38)
Oncology
(34)
Hematopoietic Stem Cell Transplantation
(33)
Biological And Medical Sciences
(29)
Transplantation, Homologous
(29)
Medical Sciences
(28)
Aged
(26)
Adolescent
(23)
Stem Cell Transplantation
(23)
Animals
(22)
Hematology, Oncology And Palliative Medicine
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

State-of-the-art acute and chronic GVHD treatment

PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD

Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia

VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML

In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia

Phase II clinical trial of one dose of post‐transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched‐unrelated donor transplantation

Multi‐dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML

The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma

Clofarabine followed by haploidentical stem cell transplant using fludarabine, busulfan, and total-body irradiation with post-transplant cyclophosphamide in non-remission AML

Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes

Elafin is a biomarker of graft-versus-host disease of the skin

The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation

IMPROVE-BMT: a protocol for a pilot randomised controlled trial of prehabilitation exercise for adult haematopoietic stem cell transplant recipients

Alloantigen-activated (AAA) CD4 + T cells reinvigorate host endogenous T cell immunity to eliminate pre-established tumors in mice

Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients

CD26lowPD-1+ CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia

IMPROVE-BMT: A Pilot Randomized Controlled Trial of Prehabilitation Exercise for Adult Hematopoietic Stem Cell Transplant Recipients

Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion

Seatbelts in CAR therapy: How Safe Are CARS?

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant

Suchergebnisse filtern